Navegar por autor "Grille Cancela, Zulaika"

Are There Differences in the Development of Proteinuria after Everolimus Initiation and Calcineurin Withdrawal or Not in Heart Transplantation?

2013- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; Marzoa Rivas, Raquel; [et al.]

Clinical and microbiological features of infections during post-operative period after heart transplantation

2012- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Castro Beiras, Alfonso; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; [et al.]

Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Vázquez Rodríguez, José Manuel; Barge Caballero, Gonzalo; Paniagua Martín, María Jesús; [et al.]

Comorbidities of patients attended in a heart failure clinic, including advanced HF patients

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Barge Caballero, Gonzalo; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; [et al.]

Comparison of nt-probnp and galectin-3 levels in end-stage heart failure and 3 months after heart transplantation

2014- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Castro Beiras, Alfonso; Suárez Fuentetaja, Natalia; Paniagua Martín, María Jesús; [et al.]

Evolution of soluble hla-g levels before and after heart transplantation: prognostic value

2014- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Fernandez Arias, Laura; Domenech García, Nieves; Castro Beiras, Alfonso; [et al.]

Incidence of cardiac acute rejection after late replacement of calcineurin inhibitors by a proliferation signal inhibitor

2011- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Castro Beiras, Alfonso; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; [et al.]

Incidence of Proteinuria after Initiation of Everolimus in Heart Transplantion. May It Have Repercussion on Renal Function?

2013- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; Marzoa Rivas, Raquel; [et al.]

Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

2012- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Domenech García, Nieves; Castro Beiras, Alfonso; Suárez Fuentetaja, Natalia; [et al.]

Informe del registro Español de Tumores Postrasplante Cardiaco

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; Marzoa Rivas, Raquel; [et al.]

Mitochondrial haplogroups H and J: Risk and protective factors for ischemic cardiomyopathy

2012- BLANCO GARCIA, FRANCISCO JAVIER; Crespo Leiro, Marisa; Domenech García, Nieves; Fernández Caggiano, Mariana; Barallobre Barreiro, Javier; [et al.]

Prognostic Significance of Heart Rate and its Long-term Trend in Cardiac Transplant Patients

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Cuenca Castillo, Jose Joaquin; Castro Beiras, Alfonso; Barge Caballero, Gonzalo; [et al.]

Relation between the evolution of soluble ST2 and coronary allograft vasculopathy in heart transplanted patients

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Vázquez Rodríguez, José Manuel; Barge Caballero, Gonzalo; Paniagua Martín, María Jesús; [et al.]

Risk Factors for Nosocomial Infection in the Post-Operative Period after Heart Transplantation

2012- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Fojón Polanco, Salvador; Cuenca Castillo, Jose Joaquin; Castro Beiras, Alfonso; [et al.]

Super-response to guideline-directed medical therapy in patients with new-onset heart failure and reduced left ventricular ejection fraction

2014- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Castro Beiras, Alfonso; Paniagua Martín, María Jesús; Grille Cancela, Zulaika; [et al.]

Utilidad de la escala INTERMACS para estratificar el pronóstico tras el trasplante cardiaco urgente

2011- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Solla Buceta, Miguel Antonio; Cuenca Castillo, Jose Joaquin; Campo Pérez, Rosa María; [et al.]

Repositorio digital RUNA

Navegar por autor "Grille Cancela, Zulaika"

Are There Differences in the Development of Proteinuria after Everolimus Initiation and Calcineurin Withdrawal or Not in Heart Transplantation? ﻿

Clinical and microbiological features of infections during post-operative period after heart transplantation ﻿

Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results ﻿

Comorbidities of patients attended in a heart failure clinic, including advanced HF patients ﻿

Comparison of nt-probnp and galectin-3 levels in end-stage heart failure and 3 months after heart transplantation ﻿

Evolution of soluble hla-g levels before and after heart transplantation: prognostic value ﻿

Incidence of cardiac acute rejection after late replacement of calcineurin inhibitors by a proliferation signal inhibitor ﻿

Incidence of Proteinuria after Initiation of Everolimus in Heart Transplantion. May It Have Repercussion on Renal Function? ﻿

Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation ﻿

Informe del registro Español de Tumores Postrasplante Cardiaco ﻿

Mitochondrial haplogroups H and J: Risk and protective factors for ischemic cardiomyopathy ﻿

Prognostic Significance of Heart Rate and its Long-term Trend in Cardiac Transplant Patients ﻿

Relation between the evolution of soluble ST2 and coronary allograft vasculopathy in heart transplanted patients ﻿

Risk Factors for Nosocomial Infection in the Post-Operative Period after Heart Transplantation ﻿

Super-response to guideline-directed medical therapy in patients with new-onset heart failure and reduced left ventricular ejection fraction ﻿

Utilidad de la escala INTERMACS para estratificar el pronóstico tras el trasplante cardiaco urgente ﻿

Are There Differences in the Development of Proteinuria after Everolimus Initiation and Calcineurin Withdrawal or Not in Heart Transplantation?

Clinical and microbiological features of infections during post-operative period after heart transplantation

Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results

Comorbidities of patients attended in a heart failure clinic, including advanced HF patients

Comparison of nt-probnp and galectin-3 levels in end-stage heart failure and 3 months after heart transplantation

Evolution of soluble hla-g levels before and after heart transplantation: prognostic value

Incidence of cardiac acute rejection after late replacement of calcineurin inhibitors by a proliferation signal inhibitor

Incidence of Proteinuria after Initiation of Everolimus in Heart Transplantion. May It Have Repercussion on Renal Function?

Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

Informe del registro Español de Tumores Postrasplante Cardiaco

Mitochondrial haplogroups H and J: Risk and protective factors for ischemic cardiomyopathy

Prognostic Significance of Heart Rate and its Long-term Trend in Cardiac Transplant Patients

Relation between the evolution of soluble ST2 and coronary allograft vasculopathy in heart transplanted patients

Risk Factors for Nosocomial Infection in the Post-Operative Period after Heart Transplantation

Super-response to guideline-directed medical therapy in patients with new-onset heart failure and reduced left ventricular ejection fraction

Utilidad de la escala INTERMACS para estratificar el pronóstico tras el trasplante cardiaco urgente